Expression profile, clinical significance and biological functions of IGF2BP2 in esophageal squamous cell carcinoma

  • Authors:
    • Fenying Lu
    • Weichang Chen
    • Tingwang Jiang
    • Cuie Cheng
    • Bin Wang
    • Zhiping Lu
    • Guojin Huang
    • Jiaming Qiu
    • Wei Wei
    • Ming Yang
    • Xia Huang
  • View Affiliations

  • Published online on: February 1, 2022     https://doi.org/10.3892/etm.2022.11177
  • Article Number: 252
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The ectopic expression of insulin‑like growth factor 2 mRNA‑binding protein 2 (IGF2BP2) has been demonstrated to facilitate tumorigenesis and induce proliferation in a various types of cancer. However, the role of IGF2BP2 in esophageal squamous cell carcinoma (ESCC) has yet been fully elucidated. In this regard, the current study assessed the expression patterns and clinical significance of IGF2BP2 in 94 Chinese patients diagnosed with ESCC. Immunohistochemistry and reverse transcription‑quantitative PCR assays were employed to assess IGF2BP2 expression in ESCC tissues compared with adjacent healthy tissues. The results revealed that the protein expression of IGF2BP2 was substantially upregulated in ESCC tissues compared with adjacent ESCC tissues. More specifically, higher IGF2BP2 expression strongly associated with tumor node metastasis stage, lymphatic infiltration and lymph node metastasis. Using two ESCC cell lines (TE‑1 and TE‑10), the inhibition of IGF2BP2 expression by small interfering RNA was proven to induce apoptosis and suppress proliferation, migration and cell cycle progression in vitro. Collectively, the present findings indicated that IGF2BP2 may serve a major role in the development of ESCC carcinogenesis. The present study may be helpful in the design of potential drug targets in the treatment of ESCC.
View Figures
View References

Related Articles

Journal Cover

April-2022
Volume 23 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Lu F, Chen W, Jiang T, Cheng C, Wang B, Lu Z, Huang G, Qiu J, Wei W, Yang M, Yang M, et al: Expression profile, clinical significance and biological functions of IGF2BP2 in esophageal squamous cell carcinoma. Exp Ther Med 23: 252, 2022.
APA
Lu, F., Chen, W., Jiang, T., Cheng, C., Wang, B., Lu, Z. ... Huang, X. (2022). Expression profile, clinical significance and biological functions of IGF2BP2 in esophageal squamous cell carcinoma. Experimental and Therapeutic Medicine, 23, 252. https://doi.org/10.3892/etm.2022.11177
MLA
Lu, F., Chen, W., Jiang, T., Cheng, C., Wang, B., Lu, Z., Huang, G., Qiu, J., Wei, W., Yang, M., Huang, X."Expression profile, clinical significance and biological functions of IGF2BP2 in esophageal squamous cell carcinoma". Experimental and Therapeutic Medicine 23.4 (2022): 252.
Chicago
Lu, F., Chen, W., Jiang, T., Cheng, C., Wang, B., Lu, Z., Huang, G., Qiu, J., Wei, W., Yang, M., Huang, X."Expression profile, clinical significance and biological functions of IGF2BP2 in esophageal squamous cell carcinoma". Experimental and Therapeutic Medicine 23, no. 4 (2022): 252. https://doi.org/10.3892/etm.2022.11177